Safety reporting in CTIS
CTs in EU/EEA within Directive and CTR). Obligation as of CT-3 to investigators (new safety data or change in B/R) and ECs according to national legislations in MSs with ongoing CTs within Directive remains. SUSARs to EV unless the NCA requires direct reporting. Reporting obligations as …
Download Safety reporting in CTIS
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
2021 Drake Software License and Non-Disclosure Agreement
www.drakesoftware.comThis Agreement is effective immediately upon opening, installing or using the Software, ... General Data Protection Regulation: Drake does not market the Software to persons residing in the European Economic Area (“EEA”) and the Software is not intended for use inside the EEA. By using the Software, Licensee
Know Your Rights English Version
travel.state.gov• An agreement by your employer to abide by all laws in the United States; • Information on the frequency and form of payment, work duties, weekly work hours, holidays, sick days, and vacation days; and • An agreement by your employer not to keep your passport, employment contract, or other personal property from you.
Non-disclosure agreements - Hogan Lovells
www.hoganlovells.comAll EU member states and members of the EEA must comply with the minimum standards set out in the Data Protection Directive (95/46/EC). The Directive’s key provisions include the following: † The rules apply to “personal data”, in other words, information which relates to an identifiable individual (a “data subject”).
European Medicines Agency post-authorisation procedural ...
www.ema.europa.euIceland, Liechtenstein and Norway by virtue of the EEA agreement, are outlined in the relevant sections of the text. European Medicines Agency post-authorisation procedural advice for …
Case M.8124 Microsoft / LinkedIn REGULATION (EC) No 139 ...
ec.europa.eu2 OJ L 1, 3.1.1994, p. 3 (the 'EEA Agreement'). 3 Publication in the Official Journal of the European Union No C 388, 21.10.2016, p. 4. In the published version of this decision, some information has been omitted pursuant to Article 17(2) of Council Regulation (EC) No 139/2004 concerning non-disclosure of business secrets and
2015 No. 102 PUBLIC PROCUREMENT - Legislation.gov.uk
www.legislation.gov.uk86. Notices of decisions to award a contract or conclude a framework agreement 87. Standstill period CHAPTER 6 APPLICATIONS TO THE COURT 88. Interpretation of Chapter 6 89. Duty owed to economic operators from EEA states 90. Duty owed to economic operators from certain other states 91. Enforcement of duties through the Court 92.